ICON, under the partnership with a trusted generic manufacturer has developed both the products following an extensive quality and technical assessment process undertaken by qualified experts in 2005.
With this acquisition, WCG has rights to Roselle and Optinor and a partner in making these branded products available to International Planned Parenthood Federation’s (IPPF) network of Member Associations located in over 170 countries.
ICON general manager David Smith said that the partnership with WCG is a significant step forward in expanding access to generic hormonal contraceptives at competitive prices.
WCG chief operating officer Saundra Pelletier said that the addition of these 2 new products to their portfolio would make a difference to women who deserve access to affordable products.